Wednesday, July 1, 2015

Regenicin readying clinical trials of NovaDerm skin substitute

Regenicin readying clinical trials of NovaDerm skin substitute

June 30, 2015 by · Leave a Comment 

http://www.youtube.com/watch?v=o1ewAheYSXs’]

Tweet Regenicin (OTC:RGIN) is completing validation of its NovaDerm skin substitute at a leading institute of technology in the U.S and plans to seek FDA approval to move into clinical trials in the second half of 2015 as well as file for worldwide designation of NovaDerm as an orphan product. “We expect to be in […]

biOasis to file IND for HER2+ brain cancer treatment in 2016

biOasis to file IND for HER2+ brain cancer treatment in 2016

June 23, 2015 by · Leave a Comment 

Tweet biOasis (OTCQX:BIOAF; TSX-V:BTI) hopes to file an Investigational New Drug application with the FDA next year to begin human testing of its Transcend platform against HER2 positive brain tumors, which result from HER2+ breast cancer metastasizing to the brain. “Given the significant unmet medical need of this condition, we are in discussions for a […]

Inogen POCs represent paradigm shift in oxygen therapy

Inogen POCs represent paradigm shift in oxygen therapy

June 16, 2015 by · Leave a Comment 

http://www.youtube.com/watch?v=dbahosqqcvs’]

Tweet Inogen (NASDAQ:INGN) is continuing to convert patients with lung disease from bulky oxygen tanks that need to be refilled every two weeks to its lightweight, portable oxygen concentrator (POC) that continuously extracts oxygen from the air in the atmosphere and can be carried over the shoulder. “With POCs, patients can breathe easy while maintaining […]

Titan Pharma Phase 3 data validate ProNeura technology

Titan Pharma Phase 3 data validate ProNeura technology

June 9, 2015 by · Leave a Comment 

Tweet Titan Pharmaceuticals’ (OTCQB:TTNP) positive topline results from a Phase 3 clinical study of Probuphine, its subdermal implant of buprenorphine for the long-term maintenance treatment of opioid addiction, validate the company’s ProNeura continuous drug delivery technology. Yesterday, the company reported that the PRO-814 Phase 3 study, comparing maintenance treatment with Probuphine to treatment with a […]

KAHR Medical on financing trail to develop dual signaling proteins

KAHR Medical on financing trail to develop dual signaling proteins

June 2, 2015 by · Leave a Comment 

Tweet Closely-held KAHR Medical of Israel is seeking to raise* as much as $10-million in the U.S. and Europe to continue development of its dual signaling proteins (DSPs), including KAHR-102, its lead drug candidate for the treatment of an orphan indication in lymphoma. “The current round will fund the company’s activities until mid-2017 and will […]

Provectus taking novel path to treat cancer

Provectus taking novel path to treat cancer

May 19, 2015 by · Leave a Comment 

Tweet Rather than taking a biochemistry approach to develop drugs that kill cancer cells, Provectus Biopharmaceuticals (NYSE MKT:PVCT) is using physical chemistry by harnessing the unique properties of Rose Bengal, a first-in-class halogenated xanthene. “We are taking a different type of molecule and a different basis for the mechanism of action than has been used […]

T2 Biosystems to double sales force this year

T2 Biosystems to double sales force this year

May 12, 2015 by · Leave a Comment 

Tweet T2 Biosystems (NASDAQ:TTOO), which entered 2015 with seven direct sales reps, plans to add another eight during the year as it continues to roll out its first products: the T2Candida panel and T2Dx instrument for the detection of Candida fungal infections that cause sepsis. “Our focus is on closing 30 accounts this year within […]

Axcelon leverages bacterial cellulose expertise with Nanoderm launch

Axcelon leverages bacterial cellulose expertise with Nanoderm launch

May 5, 2015 by · Leave a Comment 

Tweet Axcelon Biopolymers, which plans to go public in the current quarter, has developed a sales and marketing plan with a leading wholesaler and its own sales team to gain maximum market share in Canada for its Nanoderm bacterial cellulose dressing to heal burns and wounds. “We also have ongoing discussions with local distributors in […]

TransEnterix readying FDA filing of SurgiBot in mid-year

TransEnterix readying FDA filing of SurgiBot in mid-year

April 28, 2015 by · Leave a Comment 

http://www.youtube.com/watch?v=L6Bbk1MvHN0′]

Tweet TransEnterix (NYSE MKT:TRXC) plans to file for FDA approval in mid-year of its SurgiBot robotic platform to enhance minimally invasive laparoscopic surgery through a single surgical incision. “We anticipate a six-to-nine month review cycle for our 510(k) submission and hope to launch in the first half of 2016,” CEO, Todd Pope, says in an […]

In conversation with Dr. Shai Yarkoni

In conversation with Dr. Shai Yarkoni

April 21, 2015 by · Leave a Comment 

http://www.youtube.com/watch?v=VRkLBen0HaE’]

Tweet As a co-founder and CEO of Cellect Biotechnology (TASE:CLBD), Dr. Shai Yarkoni has more than 15 years of clinical and management experience in the biopharmaceutical industry. He is the founder of five start-ups in the life-sciences field, and serves on the board of noted institutes in Israel and the world. Prior to founding Cellect, […]

Next Page »

Email Newsletters with Constant Contact
Google+